Alta Stomatology is a company dedicated to the research and development of drugs for oral diseases. We can provide comprehensive drug discovery services tailored to your needs. Our services begin from the initial stages of drug development, utilizing advanced cutting-edge technologies combined with efficient and professional early-stage research. We can identify and confirm the targets associated with oral diseases, screen lead compounds, optimize lead compounds, and conduct early safety screenings and drug modification studies to obtain candidate compounds with drug-like properties. If you have any needs, please feel free to contact us.
Our Services
At Alta Stomatology, we understand the complexities involved in the discovery and development of effective drugs for oral diseases. Our team of experienced scientists, researchers, and experts collaborate seamlessly to deliver customized solutions across various stages of drug discovery. Our services include:
Target Identification and Validation Target Characterization
Target Discovery
Leveraging genomics, proteomics, and advanced technologies, Alta Stomatology offer one-stop oral disease drug target discovery services, identifying key proteins, enzymes, or cellular structures related to oral diseases, and aiding in the development of new oral disease treatments.
High Throughput Screening (HTS) Fragment-Based Screening Affinity Selection Mass Spectrometry (ASMS) Screening Virtual Screening DNA-Encoded Libraries (DEL)
Hit Identification
At Alta Stomatology, we offer a range of hit identification services that leverage advanced technologies and expertise to accelerate the drug discovery process for oral health conditions. Our services include high throughput screening, fragment-based screening, ASMS screening, virtual screening, and DNA-encoded libraries (DEL).
High Throughput Screening (HTS) Virtual Screening Structure-Activity Relationship (SAR) Studies
Hit to Lead
Alta Stomatology accelerates oral disease drug discovery by employing cutting-edge technologies and expertise in medicinal and computational chemistry, and structural biology. Through high-throughput screening and advanced methodologies, we swiftly identify most potential drug candidates from a vast pool of compounds.
Structure-Activity Relationship (SAR) Analysis Pharmacokinetics and ADME In vitro and In vivo Testing Biophysical Assays
Lead Optimization
Alta Stomatology can provide our clients with high-quality lead compound optimization services. With extensive experience in drug R&D, chemical modification, and biological testing, our expert team can enhance compound activity, selectivity, and stability, tackling issues like toxicity and low bioavailability, and ensuring improved efficacy, solubility, and pharmacokinetic properties.
Research Platforms
| Chemical Technology Platform |
Computer-Aided Drug Design Platform |
Recombinant Protein Expression Platform |
| Antibody Discovery and Affinity Maturation Platform |
Antibody Production and Identification Platform |
Antigen-Antibody Structure Analysis Platform |
Our Technology
| Next-Generation Sequencing (NGS) |
Microarray Analysis |
Mass Spectrometry |
| X-ray Crystallography and Cryo-Electron Microscopy |
Nuclear Magnetic Resonance (NMR) |
High-Throughput Screening (HTS) |
| Computational Docking |
Pharmacophore Modeling |
Structure-Activity Relationship (SAR) Studies |
| Quantitative Structure-Activity Relationship (QSAR) Modeling |
Molecular Dynamics Simulations |
Others |
Why Choose Alta Stomatology?
Our team of experienced scientists and researchers brings a wealth of expertise in drug discovery, molecular biology, and translational medicine.
We offer a comprehensive suite of services encompassing target discovery, lead identification, and optimization, streamlining the drug discovery process and maximizing efficiency.
We value collaboration and partnerships, working closely with our clients to understand their unique needs and objectives. Whether you are a pharmaceutical company, academic institution, or biotech startup, we are committed to forging productive collaborations that accelerate drug discovery.
For research use only. Not
intended for any clinical use.
